Fulcrum Therapeutics Inc (FULC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 50,261 | 197,533 | 47,078 | 42,588 | 42,178 |
| Marketable Securities | 283,055 | 154,773 | 153,567 | 171,523 | 184,425 |
| Receivables | N/A | N/A | N/A | N/A | 979 |
| TOTAL | $338,669 | $357,480 | $205,863 | $219,373 | $232,556 |
| Non-Current Assets | |||||
| PPE Net | 2,494 | 2,824 | 3,171 | 3,269 | 3,547 |
| Other Non-Current Assets | 5,607 | 5,980 | 5,824 | 6,196 | 6,546 |
| TOTAL | $8,101 | $8,804 | $8,995 | $9,465 | $10,093 |
| Total Assets | $346,770 | $366,284 | $214,858 | $228,838 | $242,649 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,450 | 1,592 | 2,856 | 1,751 | 1,507 |
| Accrued Expenses | 4,953 | 9,052 | 6,428 | 4,941 | 4,354 |
| TOTAL | $9,864 | $13,048 | $11,632 | $8,985 | $8,100 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,603 | 4,236 | 4,860 | 5,475 | 6,063 |
| TOTAL | $3,603 | $4,236 | $4,860 | $5,475 | $6,063 |
| Total Liabilities | $13,467 | $17,284 | $16,492 | $14,460 | $14,163 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 66,633 | 66,600 | 54,118 | 54,092 | 53,979 |
| Common Shares | 67 | 67 | 54 | 54 | 54 |
| Retained earnings | -613,169 | -594,278 | -573,944 | -554,349 | -537,053 |
| Other shareholders' equity | -513 | 174 | 241 | 82 | 70 |
| TOTAL | $333,303 | $349,000 | $198,366 | $214,378 | $228,486 |
| Total Liabilities And Equity | $346,770 | $366,284 | $214,858 | $228,838 | $242,649 |